로딩 중…
지수 로딩 중…
Kiniksa Pharmaceuticals, Ltd.
KNSA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
BM
BM$55.29+1.99%
2026-06-18
Price Chart
Kiniksa Pharmaceuticals, Ltd.+97.96%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $4.25B |
| Revenue | $754M |
| Net Income | $73M |
| Total Assets | $825M |
| Net Assets | $606M |
| Value | |
| P/E | 58.23x |
| P/B | 7.02x |
| PEG | 0.35x |
| P/S | 5.64x |
| EV/EBITDA | 40.12x |
| FCF Yield | 3.86% |
| Profitability | |
| ROE | 12.06% |
| ROA | 8.85% |
| Op. Margin | 12.36% |
| Revenue Growth | 55.51% |
| Earnings Growth | 164.57% |
| Financial Health | |
| Debt Ratio | 36.26% |
| Total Debt | $9M |
| FCF | $164M |
| Cash | $190M |
| Current Ratio | 3.79x |
| Net Debt/EBITDA | -1.78x |
| Performance | |
| 1Y Return | 97.96% |
| 1M Return | 3.66% |
| From 52W High | -7.65% |
| 1Y MDD | -21.12% |
| Trading | |
| Volume | 714,213 shares |
| Trading Value | $39M |
| Per Share | |
| EPS | $0.80 |
| BPS | $7.65 |